Teriparatide use during an economic crisis: Baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS) Epidemiology of musculoskeletal disorders

Abstract

Background: The Extended Forsteo Observational Study (ExFOS) is a multinational, non-interventional, prospective, observational study that aims to provide real-life data on patients with osteoporosis treated with teriparatide for up to 24 months. It includes the new indications of osteoporosis in men and glucocorticoid-induced osteoporosis (GIOP). We describe the Greek subpopulation enrolled in this study and compare it with a similar cohort from the previous European Forsteo Observational Study (EFOS). Methods: Baseline data were collected from the Greek cohort of ExFOS. Data included demographic characteristics, medical and osteoporosis history, disease status, prior use of medications, back pain and quality of life. Results: Baseline data for 439 patients, enrolled at 31 sites, indicated the majority of patients were females (92.3 %), elderly [mean (standard deviation; SD) age 70.1 (9.8) years] and slightly overweight [mean (SD) body mass index 26.7 (4.3) kg/m2], with very low bone mineral density (mean T-score∈